Avid Bioservices Inc (CDMO)
10.49
+0.22
(+2.14%)
USD |
NASDAQ |
Nov 04, 13:05
Avid Bioservices Profit Margin (Quarterly): -13.78% for July 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | -13.78% |
| April 30, 2024 | -286.5% |
| January 31, 2024 | -17.76% |
| October 31, 2023 | -37.49% |
| July 31, 2023 | -5.62% |
| April 30, 2023 | -0.84% |
| January 31, 2023 | -0.65% |
| October 31, 2022 | -1.50% |
| July 31, 2022 | 3.71% |
| April 30, 2022 | |
| January 31, 2022 | 7.13% |
| October 31, 2021 | 13.49% |
| July 31, 2021 | 20.50% |
| April 30, 2021 | 7.21% |
| January 31, 2021 | 10.12% |
| October 31, 2020 | 10.84% |
| July 31, 2020 | 18.63% |
| April 30, 2020 | -37.99% |
| January 31, 2020 | -15.49% |
| October 31, 2019 | -2.35% |
| July 31, 2019 | -20.74% |
| April 30, 2019 | 1.97% |
| January 31, 2019 | -8.26% |
| October 31, 2018 | -14.26% |
| July 31, 2018 | -15.58% |
| Date | Value |
|---|---|
| April 30, 2018 | 43.50% |
| January 31, 2018 | -161.4% |
| October 31, 2017 | -98.76% |
| July 31, 2017 | -4.45% |
| April 30, 2017 | -29.45% |
| January 31, 2017 | -72.34% |
| October 31, 2016 | -17.36% |
| July 31, 2016 | -197.1% |
| April 30, 2016 | -64.40% |
| January 31, 2016 | -251.1% |
| October 31, 2015 | -138.6% |
| July 31, 2015 | -141.9% |
| April 30, 2015 | -130.4% |
| January 31, 2015 | -228.9% |
| October 31, 2014 | -192.1% |
| July 31, 2014 | -238.9% |
| April 30, 2014 | -158.3% |
| January 31, 2014 | -250.3% |
| October 31, 2013 | -105.9% |
| July 31, 2013 | -162.1% |
| April 30, 2013 | -198.6% |
| January 31, 2013 | -69.81% |
| October 31, 2012 | -142.6% |
| July 31, 2012 | -180.3% |
| April 30, 2012 | -527.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-286.5%
Minimum
Apr 2024
20.50%
Maximum
Jul 2021
-18.11%
Average
-0.75%
Median
Profit Margin (Quarterly) Benchmarks
| MEI Pharma Inc | -- |
| Altimmune Inc | -492.8K% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -107.0% |
| Return on Assets | -35.62% |
| Return on Invested Capital | -51.31% |
| Gross Profit Margin (Quarterly) | 14.22% |
| Operating Margin (Quarterly) | -6.11% |
| Return on Net Operating Assets | -49.36% |